UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells Journal article
Zhou, Guangyu, Fu, Shengyu, Zhang, Yunsen, Li, Shuang, Guo, Ziang, Ouyang, Defang, Ying, Tianlei, Lu, Yinying, Zhao, Qi. Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells[J]. Antibodies, 2024, 13(2), 45.
Authors:  Zhou, Guangyu;  Fu, Shengyu;  Zhang, Yunsen;  Li, Shuang;  Guo, Ziang; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.0/4.7 | Submit date:2024/08/05
Car-t Cell  Her2  Monoclonal Antibody  Trastuzumab  
Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions Journal article
Liu, Chunping, Chen, Huiqi, Guo, Sien, Liu, Qiaojing, Chen, Zhijun, Huang, Haiding, Zhao, Qi, Li, Longmei, Cen, Huan, Jiang, Zebo, Luo, Qiyuan, Chen, Xiaoling, Zhao, Jiaxiong, Chen, Wensheng, Yang, Phillip C., Wang, Lei. Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions[J]. Biomedicine and Pharmacotherapy, 2023, 166.
Authors:  Liu, Chunping;  Chen, Huiqi;  Guo, Sien;  Liu, Qiaojing;  Chen, Zhijun; et al.
Favorite | TC[WOS]:7 TC[Scopus]:9  IF:6.9/6.8 | Submit date:2024/01/10
Anthracycline  Breast cancer  Cardiomyopathy  Cardiotoxicity  Chemotherapy  Trastuzumab  
Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions Review article
2023
Authors:  Chunping Liu;  Huiqi Chen;  Sien Guo;  Qiaojing Liu;  Zhijun Chen; et al.
Favorite | TC[WOS]:7 TC[Scopus]:9  IF:6.9/6.8 | Submit date:2023/09/22
Anthracycline  Breast Cancer  Cardiomyopathy  Cardiotoxicity  Chemotherapy  Trastuzumab